Quantcast

Torrent Pharma, others named in suit over allegedly contaminated medication

LEGAL NEWSLINE

Saturday, November 23, 2024

Torrent Pharma, others named in suit over allegedly contaminated medication

Lawsuits
Medical malpractice 01

TRENTON, N.J. (Legal Newsline) – A North Carolina man alleges he was injured by ingesting a prescription medication he alleges contained a carcinogen.

Ira Sanders filed a complaint on behalf of himself and all others similarly situated on Jan. 24 in the U.S. District Court for the District of New Jersey against Torrent Pharma Inc., The Kroger Co., Harris Teeter LLC and Harris Teeter Supermarkets Inc. alleging breach of express warranty and other counts.

According to the complaint, the plaintiff alleges that Torrent manufactured losartan-containing generic prescription medications that were contaminated with carcinogen N-Nitrosodiethylamine (NDEA). The suit states the medications are used to treat high blood pressure, diabetic kidney disease and other issues and the manufacturing defects originated from labs in India.

The plaintiff holds Torrent Pharma Inc., The Kroger Co., Harris Teeter LLC and Harris Teeter Supermarkets Inc. responsible because he and the class were allegedly injured when they purchased worthless medication that is not fit for human consumption and by ingesting an acutely toxic substance.

The plaintiffs request a trial by jury and seek judgment against the defendants; certify class action; declaratory and injunctive relief; compensatory, statutory, treble, and punitive damages; interest; restitution; attorneys’ fees; expenses; and costs of suit. He is represented by Andrew J. Obergfell of Bursor & Fisher PA in New York.

U.S. District Court for the District of New Jersey case number 3:19-cv-01017

More News